_p.png)
Positron Emission Tomography (PET)
What is Positron Emission Tomography?
Positron Emission Tomography (PET) is a nuclear medicine functional imaging technique that is used to observe metabolic changes or processes in the body. This aids and acts as a way to diagnose of the disease. The system detects a pair of gamma rays emitted indirectly by a positron-emitting radioligand that was introduced into the body, via an injection by a trained clinical staff, on a biologically active molecule called a radioactive tracer. Different ligands are used for different imaging purposes depending on what is being imaged. Three-dimensional images of the tracer concentration inside the body are then reconstructed by computer analysis.
PET Scan of a human brain
A three-dimensional PET scan with visible tracer uptake in multiple lymph nodes.
Lung Cancer with Small Mediastinal Lymph Node Metastases
Courtesy of Siemens Healthineer for providing the above images and details
Lymphoma with visible tracer uptake in multiple lymph nodes
PET-CT Scan of the Brain
The Siemens Biograph
At ML've, we utilise a state-of-the-art tool to aid in detecting diseases earlier - the Siemens Biograph. By characterizing diseases more accurately as well as improving therapy planning and monitoring.
The Siemens Biograph is the industry's finest volumetric PET resolution, providing precise tumor contouring for more accurate treatment planning for patient-specific dose escalation.
The Siemens Biograph
The ML've PET Experience
METICULOUS PERFORMANCE
Meticulous to the finest of details, ML've deploys a unique PET/CT continuous flow technology with scanning protocols customizable to specific organ of interest, yielding precise images of refined resolution, enhancing definitive diagnostic performance.
LOW DOSE, HIGH EFFICIENCY
An advocate of patient safety, choice of PET/CT technology by ML’ve requires traces of radioactive biomarkers as low as reasonably achievable (ALARA) without compromising imaging quality and efficiency.
VERACIOUS ASSESSMENT
With evolution of the advanced PET/CT hybrid technology, precise and reproducible quantifications of imaging enable identification of disease traits and developments even at early stage, facilitating ML've partnered physicians’ veracious assessment and diagnostic confidence in formulating effective treatment regimes.
EASE AND COMFORT
Aligning with ML’ve priority for patients’ holistic care experience, our PET/CT imaging platform with inherently larger opening of the gantry as well as quieter operation accentuate patients’ ease and comfort.
